耳鼻咽喉科領域における消炎鎮痛剤SL-573の使用経験

概要

論文の詳細を見る
Clinical study of SL-573 was carried out in 20 patients with acute upper respiratory infection. The dosage of SL-573 was 200mg×3/day. The duration of administration was from 2 to 7 days.Effects of SL-573 were as follows: for sore throat in 16 cases, excellent 11 (68%), good 3 (19%) and none 2; for pain on swallowing in 15 cases, excellent 10 (67%), good 3 (20%) and none 2; for abnormal feeling of the throat in 19 cases, excellent 10 (53%), good 5 (26%) and none 4; for local reddness by objective examination in 20 cases, excellent 10 (50%), good 5 (25%) and none 5.Subjective side effects were as follows: loss of appetite 2, gastric pain 2, heavy feeling in the stomach 1, discomfort of the upper abdomen 1, nausea 1, diarrhea 1. The complaints were transient and not so severe, to the extent that they disappeared with cessation of administration. There were no definite abnormalities on laboratory tests which could be directly attributed to the administration of SL-573.